PRECISION BIOSCIENCES INC Revenue (ASC 606)

Quick Answer

PRECISION BIOSCIENCES INC reported Revenue (ASC 606) of $34.26 million for fiscal year 2025.

PRECISION BIOSCIENCES INC Revenue (ASC 606) — Annual History

Fiscal Year Revenue (ASC 606) YoY Change
2025 $34.26M -50.1%
2024 $68.70M +41.0%
2023 $48.73M +94.1%
2022 $25.10M -78.3%
2021 $115.53M +375.7%
2020 $24.29M +9.2%
2019 $22.24M +104.3%
2018 $10.88M

Quarterly Revenue (ASC 606)

Quarter Ending Revenue (ASC 606) YoY QoQ
September 30, 2025 $13.0K -97.7% -27.8%
June 30, 2025 $18.0K -100.0% -37.9%
March 31, 2025 $29.0K -99.8% -95.0%
September 30, 2024 $576.0K -95.6% -98.8%
June 30, 2024 $49.90M +152.2% +183.8%
March 31, 2024 $17.58M +100.3% +34.0%
September 30, 2023 $13.12M +78.2% -33.7%
June 30, 2023 $19.79M +418.0% +125.4%
  • PRECISION BIOSCIENCES INC showed a decrease of -50.1% in Revenue (ASC 606) compared to the prior fiscal year.
  • Over the 2018–2025 period, PRECISION BIOSCIENCES INC’s revenue (asc 606) has grown by 214.8% (from $10.88 million to $34.26 million).
  • The most recent figure is from PRECISION BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment